Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
about
SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infectionEngineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT miceSubstitution of the Rev-response element in an HIV-1-based gene delivery system with that of SIVmac239 allows efficient delivery of Rev M10 into T-lymphocytes.Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interfaceProtein methylation is required to maintain optimal HIV-1 infectivityThe Vpr protein from HIV-1: distinct roles along the viral life cycleA dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infectionCodon-usage-based inhibition of HIV protein synthesis by human schlafen 11Translational repression precedes and is required for ZAP-mediated mRNA decayCHD1 and CHD2 are positive regulators of HIV-1 gene expressionThe histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcriptionThe human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infectionImportin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replicationZinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradationHIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasomeMechanism of allosteric activation of SAMHD1 by dGTPTMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike proteinHuman immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription.Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factorHuman immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayHuman immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylasesViral protein R regulates nuclear import of the HIV-1 pre-integration complexFunctional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmissionDifferential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNRPhosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophagesHepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNRLEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexesHIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activatorHIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomesAPOBEC3G contributes to HIV-1 variation through sublethal mutagenesisSAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesTetramerization of SAMHD1 is required for biological activity and inhibition of HIV infectionAccess of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repairDDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrestUracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrestDC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by plateletsRole of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection
P2860
Q21089603-17480CC5-2D5A-4700-9309-A6C4DD2F7A93Q21133769-4142C71C-EEE8-4507-8A26-A1633D64B6A7Q21245027-0C3D2283-E095-4F5B-BF41-E9E7CBC8CD80Q21245044-208E365E-86ED-47BB-87BD-C42C2A77D5CDQ21245198-C3FC20E8-38D3-4BE2-93B8-5B4C19584904Q21245211-F4B1E9FA-AAB0-4BD1-AF6E-FDD5ED86789EQ24290940-C0B3ABDD-FC53-4B9D-A1B8-7E118B444BB6Q24299226-8A4F7880-3597-459A-83B5-6602FB0AA8BFQ24299914-F572B6F7-6961-489D-9693-5143EB074AFBQ24305354-CEB6D3F6-E818-4EF5-9040-B8CDC676DCE8Q24307870-29BBD438-D724-48F8-870F-979B101331C1Q24318267-2B79A324-AF2A-4390-A60D-DEA589F753FDQ24322708-D9F96C57-425E-4F24-AE2B-E3F22D078593Q24336663-EA7330CA-1C5A-42F2-A903-F64D944CC4DCQ24338212-8A53B5A6-BFBA-4A4D-88FD-B7ABE4A2B4F6Q24338757-EE74F7D0-93EF-4B81-9094-49B07088EC3BQ24339582-CE192488-09C0-4D74-AD77-0EAA7C31F0CDQ24523263-B73E4D1A-B085-48C2-95AF-1BE70A99A92CQ24523655-DB56147C-2839-484B-A13C-F09DFA9BCC5FQ24523667-592090B9-1CB5-47B4-BDC1-23DA8CC10357Q24529956-0C379625-F291-4E6F-8F4E-27FB624E2225Q24530134-04CD214F-FD9F-432B-81BC-C7D5932627AAQ24530147-044FFC69-5579-4DEE-BFE4-3677CBAC3DF7Q24533072-2FCE8ADF-8FFF-4214-B297-F0F8250B3429Q24537674-43BB83C1-D9EF-4EF9-98D1-CBA9FCB22ACAQ24541155-C36F2C67-9D03-4B74-AB07-FDE200BE8137Q24541375-2613FB7F-5F93-4DAB-A3B7-653182A78515Q24551041-6C7920DA-B138-42DF-9A92-0E0E081136CFQ24562936-609EF896-84F5-42A5-8170-0A37DDB49F4BQ24569559-EF730D0C-3F13-48A4-B7FA-867452EBC8D5Q24610197-41DBEB0B-4BF1-4A62-BEDF-370BF3B17EC6Q24618320-1A5FBD19-BB3B-4F3F-8C1B-DB7018211E79Q24624362-5C0B6668-8C24-4B2F-B299-5313A8326C95Q24634238-5A3B6427-475E-42D3-A1F6-9000E9392CB3Q24645530-F593B050-3ED2-492C-9006-362B2C0E2337Q24653439-E81248EA-A9A5-400C-954B-6D878D3A9076Q24671784-7AE7A1D8-3588-4412-9F49-6203C3063018Q24673660-F23E9ECC-DAE9-4322-9069-0F9E6DAEA294Q24673797-F7B870BC-BDA0-4836-BDD5-37542CAB7A6BQ24673913-0E44C20B-F674-489D-8CC1-7AAEB355A394
P2860
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
description
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Februar 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: February 1995)
@en
wetenschappelijk artikel (gepubliceerd op 1995/02/01)
@nl
наукова стаття, опублікована в лютому 1995
@uk
مقالة علمية (نشرت في فبراير 1995)
@ar
name
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@ast
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@en
type
label
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@ast
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@en
prefLabel
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@ast
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@en
P2093
P3181
P356
P1433
P1476
Vpr is required for efficient ...... pe-1 in mononuclear phagocytes
@en
P2093
P304
P3181
P356
10.1006/VIRO.1995.1016
P407
P577
1995-02-01T00:00:00Z